Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery

NCT06818409 is registered in ClinicalTrials.gov with Ankara Ataturk Sanatorium Training and Research Hospital as lead sponsor.

NCT NCT06818409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06818409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is the CRP-Albumin-Lymphocyte (CALLY) Index Effective in Predicting Postoperative Delirium in Geriatric Patients Undergoing Hip Fracture Surgery
Lead sponsor
Ankara Ataturk Sanatorium Training and Research Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 6, 2025
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albumin, crp, hip fracture, lymphocyte, postoperative delirium (pod)